Regenerative Psychiatry, Neuroplasticity & Cognitive Performance Medicine
Josh Swigart, APRN, PMHNP-BC
Josh Swigart,
APRN, PMHNP-BC
We treat the biology beneath the symptoms, restoring function for treatment-resistant depression, PTSD, anxiety, ADHD, addiction, and cognitive performance.
We treat the biology beneath the symptoms, restoring function for treatment-resistant depression, PTSD, anxiety, ADHD, addiction, and cognitive performance.
TWO TRACKS OF CARE
Proactive Track
Psychiatric Prevention, Neurocognitive Risk Reduction & Cognitive Performance Restoration
For patients acting on psychiatric or neurocognitive risk before symptoms become severe - including cognitive decline risk, postpartum vulnerability, burnout, declining resilience, cognitive performance deterioration, or known biological risk factors such as APOE4 or family history.
Your plan is anchored in objective findings from advanced labs, diagnostic brain assessments, and relevant genetic markers.
Reactive Track
Neurobiological Psychiatric Care
For patients with active psychiatric symptoms or functional impairment — including treatment-resistant depression, PTSD, ADHD, postpartum mood disorders, major depressive disorder, anxiety, sleep-related psychiatric dysfunction, or substance-related psychiatric concerns.
A DIFFERENT PHILOSOPHY
Biology before Behavior
.png)
Biological Repair
Sleep architecture, inflammation, hormones, mitochondrial function, autonomic tone, nutrient status, and neuroplasticity are evaluated and addressed.
.png)
Functional Capacity Returns
Energy, focus, emotional regulation, mood recovery, motivation, and stress tolerance begin to improve as the biological foundation stabilizes.
.png)
Behavior Becomes Sustainable
Patients are better able to follow through on sleep, nutrition, movement, therapy, work, relationships, and long-term psychiatric resilience.
We start by measuring how your system is functioning - not guessing from symptoms alone. Advanced labs, neurochemical assessment, WAVi EEG, Brain Gauge testing, HRV patterns, and clinical history help identify the biological drivers behind mood, cognition, energy, stress tolerance, and performance. From there, we build a strategy matched to your physiology: restoring function where systems are depleted, and optimizing capacity where performance can be improved.
Patient Eligibility. We treat ASA I and ASA II patients only.
This includes individuals who are medically stable and appropriate candidates for outpatient regenerative psychiatry, neuroplasticity, and cognitive performance medicine.
Our Treatment Approach. Comprehensive Care Pathways
Clinical Services
NEUROCHEMICAL & RESTORATIVE THERAPIES
Ketamine-Assisted Neuroplasticity
Rapid neuroplastic change for treatment-resistant depression and trauma. One of the most evidence-supported tools available for TRD and complex trauma - KRI Fellowship-trained, lab-gated, and fully integrated with your biological protocol. Physician-guided, medically supervised, and never an infusion-bar experience.
Medicinal Signaling Therapies
Precision bioregulatory signaling for repair, resilience, and recovery. Compounded peptides and medicinal signaling therapies are selected and sequenced to your biology - supporting cellular repair, immune tone, mitochondrial function, and cognitive recovery. Every compound has a defined role and a defined cycle. Not a retail menu.
Intravenous Nutritional Therapy (IVNT)
Bespoke IV formulations calibrated to your lab findings. Clinically designed infusions - each with a defined purpose, each justified by your data, each sequenced within your individualized protocol. Not a drip bar.
Neural Therapy & Stellate Ganglion Block
Injection-based neuromodulation for autonomic dysregulation and treatment-resistant patterns. Stellate ganglion block (SGB) for PTSD, chronic sympathetic hyperactivation, and hypervigilance - used selectively, when the clinical picture supports it. Response window: 1–7 days post-procedure.
Ozone Therapy & EBOO
Advanced extracorporeal oxygenation for complex neuropsychiatry. EBOO (extracorporeal blood oxygenation and ozonation) is reserved for appropriate candidates when foundational biological work is already in place - mechanism-first framing, candidacy screened, honest clinical indication.
REGULATION & FOUNDATIONS
Cognitive Performance & Neurocognitive Prevention
Protecting and sharpening cognition, measured over time. WAVi EEG and Brain Gauge cortical metrics establish an objective baseline. Targeted protocols address processing speed, attention, memory, and early decline risk - including APOE4 carriers and patients with a family history of cognitive disease. Measured, not theoretical.
Sleep Architecture & Circadian Restoration
Clinical chronobiology is not a generic sleep protocol. Sleep architecture, cortisol rhythm, and circadian timing are recalibrated through measurement. Disrupted slow-wave sleep and circadian fragmentation sit beneath most psychiatric and cognitive symptoms; durable recovery often begins here.
HPA-Axis & Stress-Response Rehabilitation
Rebuilding the stress-response circuit behind burnout and treatment-resistant patterns. Cortisol rhythm, adrenal reserve, and HPA-axis function are assessed through labs, HRV, and clinical history - then corrected at the biological source. Restoring the capacity to recover, rather than pushing through with stimulants.
PERFORMANCE & GUIDANCE
Evidence-Based Nutraceutical & Supplement Strategy
Fewer ingredients, clearer intent, every interaction reviewed. Supplement and nutraceutical strategy built around your labs, metabolism, and protocol goals - not trends or wellness marketing. Each compound chosen for a defined biological role. When to stop matters as much as when to start. Not a wall of bottles.
Clinical Education & Biological Transparency
Understanding your biology is part of the treatment. Care at Peak Body and Mind is transparent by design - you are meant to understand how your biology connects to your symptoms and what each intervention is doing and why. Informed patients make better decisions and achieve better outcomes.
For those recovering function and those optimizing it, every intervention is selected and calibrated to your unique neurochemistry.
Josh Swigart
APRN, PMHNP-BC
Motivation is not always the starting point. For many patients, it is the restoration of biology that makes change possible.
My approach begins by measuring the systems that drive psychiatric resilience, neuroplasticity, and cognitive performance: sleep architecture, HPA-axis function, limbic regulation, mitochondrial capacity, inflammation, hormones, nutrients, WAVi EEG, Brain Gauge metrics, and HRV patterns.
When those systems are depleted, “try harder” is not enough. At Peak Body and Mind, treatment is designed to restore function first — then build the conditions for durable psychiatric recovery, neurocognitive performance, and sustained behavior change.
KRI Fellow, Ketamine Research Institute · A4M ABAAHP Fellow-in-Training · Triple Certified Peptide Therapy · Advanced IVNT Certified · Double Certified Neural Therapy · Double Certified Ozone Therapy · Koniver Method Clinician · Ketamine, Integrative Psychiatry Institute (IPI) · Integrative Psychiatry, Integrative Psychiatry Institute (IPI)
Built In High-Acuity Medicine
Josh Swigart's clinical foundation was built in some of medicine's most demanding environments, where precision, composure, and sound judgment matter.
His background spans ICU, neurology, PACU, neurosurgery, and emergency psychiatry at Renown Regional Medical Center, as well as advanced training in regenerative psychiatry, neuroplasticity, and performance medicine. That experience shapes a practice that treats psychiatric illness, cognitive dysfunction, and cognitive performance decline as biological patterns to be measured, understood, and treated, not simply labeled and managed.
APRN
PMHNP-BC
Ketamine Infusion Therapy
Functional Medicine
Oligopeptides and Polypeptides
Integrative Psychiatry
Advanced Intravenous Nutrient Delivery Systems
Performance Medicine
EBOO & Ozone Therapy
Neural Therapy
Foundational Principles
Mechanism First, Not Symptom Management
Clinically Rigorous, Not Trend-Driven
Measurable Outcomes, Not Just Reported Ones
Every Symptom Tells A Story.
Every pattern has a cause.
Every patient deserves a thoughtful investigation into why they feel the way they do and what can be done to change it.
Your information stays confidential.
Frequently Asked Questions about Custom Tools for Your Biology Needs
Yes. Peak Body and Mind has two pathways into care. Some patients come in with active psychiatric conditions such as treatment-resistant depression, PTSD, postpartum mood disorders, anxiety, ADHD, or related concerns. Others come in before symptoms become severe — seeking proactive neurocognitive assessment, psychiatric risk reduction, cognitive performance support, or a deeper biological evaluation. Both pathways rely on objective clinical data. The difference is the entry point, not the rigor.
Objective findings may include:
Brain Gauge cortical assessment - cortical processing measured across eight domains on a 0–100 scale.
WAVi EEG - objective electrophysiological data including P300 latency, peak alpha frequency, brain-age index, and brainwave pattern analysis.
HRV patterns - autonomic regulation, recovery capacity, and stress-resilience markers.
Advanced laboratory findings - hormone patterns, inflammatory markers, nutrient status, metabolic dysfunction, mitochondrial strain, methylation patterns, and related biological data.
Genetic risk markers - variants that may meaningfully change prevention strategy, risk interpretation, or clinical decision-making.
Track summary:
Proactive Track: for patients seeking early measurement, neurocognitive risk reduction, psychiatric resilience, and performance optimization before major dysfunction appears.
Reactive Track: for patients with active psychiatric symptoms or formal psychiatric diagnoses, where biological workup informs protocol selection and treatment sequencing.
The Dual-Track Care Model is how Peak Body and Mind organizes care for two different types of patients: those already experiencing psychiatric symptoms, and those seeking proactive measurement, prevention-oriented care, or cognitive optimization before symptoms become severe. Both tracks are clinical. Both use objective biological measurements. Both are protocol-based.
The Reactive Track is for patients already experiencing psychiatric symptoms or a formal psychiatric condition, such as treatment-resistant depression, PTSD, anxiety, ADHD, postpartum mood symptoms, substance-use concerns, or related mood and cognitive symptoms.
Care begins with psychiatric evaluation and biological assessment. The diagnosis helps define the clinical problem, but treatment is not based on diagnosis alone. We evaluate the systems that may be driving or sustaining symptoms — sleep architecture, inflammation, HPA-axis dysregulation, mitochondrial strain, hormones, nutrients, autonomic imbalance, and neuroplasticity markers.
Standard psychiatric care often focuses on symptom clusters and medication response. At Peak Body and Mind, medication may be part of your picture, but it is not the whole model.
The Reactive Track looks for biological barriers that may explain why symptoms persist: inflammation, hormone disruption, poor sleep architecture, autonomic hyperarousal, mitochondrial dysfunction, nutrient depletion, impaired neuroplasticity, or metabolic strain. Treatment is protocol-based and centered on the mechanisms most likely to limit recovery.
Yes. These and more are core conditions within the Reactive Track.
For these patients, we use psychiatric evaluation, advanced labs, Brain Gauge, WAVi EEG, HRV patterns, and clinical history to identify biological drivers that may sustain symptoms. Depending on the case, treatment may involve ketamine, IVNT, peptide therapy, neural therapy such as SGB or CGB, hormone optimization, sleep restoration, and targeted medication or supplement strategy — always within a protocol, not as isolated services.
Yes. Peak Body and Mind can work alongside an existing therapist, physician, or psychiatric clinician when appropriate and with patient consent.
We do not replace psychotherapy. For many patients — especially those receiving ketamine, SGB, CGB, or trauma-focused care — psychotherapy becomes even more important. Our role is to address the biological and psychiatric factors that may be limiting recovery, while existing therapeutic relationships can continue.
Generally, no. These are clinical tools, not menu-based services.
Ketamine, IVNT, peptides, SGB, CGB, hormones, supplements, and medication strategies are used only when they fit the clinical picture, safety profile, objective findings, and treatment sequence. Each intervention must serve a defined role within a broader protocol.